Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ATORVASTATIN Cause Low density lipoprotein increased? 217 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 217 reports of Low density lipoprotein increased have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.3% of all adverse event reports for ATORVASTATIN.

217
Reports of Low density lipoprotein increased with ATORVASTATIN
0.3%
of all ATORVASTATIN reports
0
Deaths
39
Hospitalizations

How Dangerous Is Low density lipoprotein increased From ATORVASTATIN?

Of the 217 reports, 39 (18.0%) required hospitalization, and 4 (1.8%) were considered life-threatening.

Is Low density lipoprotein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 217 reports have been filed with the FAERS database.

What Other Side Effects Does ATORVASTATIN Cause?

Type 2 diabetes mellitus (7,556) Myalgia (7,155) Drug hypersensitivity (3,929) Drug ineffective (3,865) Fatigue (3,439) Arthralgia (3,338) Rhabdomyolysis (3,286) Dyspnoea (3,137) Nausea (2,888) Asthenia (2,791)

What Other Drugs Cause Low density lipoprotein increased?

EVOLOCUMAB (1,024) INCLISIRAN (423) ALIROCUMAB (336) ROSUVASTATIN (241) EZETIMIBE (217) LOMITAPIDE (164) TOFACITINIB (135) FINGOLIMOD (132) SOMATROPIN (93) LORLATINIB (78)

Which ATORVASTATIN Alternatives Have Lower Low density lipoprotein increased Risk?

ATORVASTATIN vs ATORVASTATIN\EZETIMIBE ATORVASTATIN vs ATOSIBAN ATORVASTATIN vs ATOVAQUONE ATORVASTATIN vs ATOVAQUONE\PROGUANIL ATORVASTATIN vs ATRACURIUM

Related Pages

ATORVASTATIN Full Profile All Low density lipoprotein increased Reports All Drugs Causing Low density lipoprotein increased ATORVASTATIN Demographics